Company Filing History:
Years Active: 2001-2009
Title: The Innovations of Stephen T. Schlacter
Introduction
Stephen T. Schlacter is a notable inventor based in Boulder, CO (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of immunoregulatory disorders and respiratory diseases. With a total of 3 patents to his name, his work has had a considerable impact on medical science.
Latest Patents
One of Schlacter's latest patents is focused on macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases. This patent discloses compounds that are useful in treating these conditions in mammals. The compounds include various forms such as diastereomers, tautomers, and pharmaceutically acceptable salts. Another significant patent involves cyclic AMP-specific phosphodiesterase inhibitors. This patent reveals novel pyrrolidine compounds that act as potent and selective inhibitors of PDE4, which are useful in treating inflammatory diseases and central nervous system disorders.
Career Highlights
Throughout his career, Schlacter has worked with prominent companies in the pharmaceutical industry, including Icos Corporation and Array Biopharma Inc. His experience in these organizations has allowed him to develop innovative solutions to complex medical challenges.
Collaborations
Schlacter has collaborated with esteemed colleagues such as Laurence Edward Burgess and John Joseph Gaudino. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Stephen T. Schlacter's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of various diseases.